Pulse biosciences, inc. (PLSE)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Operating expenses:
General and administrative

5,603

7,174

5,606

5,146

4,401

3,814

5,675

5,173

5,383

5,801

4,434

3,924

1,344

1,027

1,079

665

528

417

408

243

156

Research and development

6,181

6,590

6,192

6,337

5,842

5,080

5,038

3,960

3,175

2,864

2,925

2,130

1,727

1,649

1,553

1,430

990

951

659

547

421

Amortization of intangible assets

166

167

166

166

167

166

166

167

166

166

166

167

166

167

166

166

166

167

167

166

166

Total operating expenses

11,950

13,931

11,964

11,649

10,410

9,060

10,879

9,300

8,724

8,831

7,525

6,221

3,237

2,843

2,798

2,261

1,684

1,535

1,234

956

743

Other income:
Interest income

78

143

218

290

332

135

118

137

56

128

39

41

39

34

31

3

0

-

-

-

-

Other

-

-

-

-

-

28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income

78

143

218

290

332

107

118

137

56

128

39

41

39

34

31

3

0

-

-

-

-

Loss from operations, before income taxes

-

-13,788

-11,746

-11,359

-

-8,953

-10,761

-9,163

-8,668

-8,703

-7,486

-6,180

-3,198

-2,809

-2,767

-2,258

-1,684

-1,535

-1,234

-956

-743

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-518

-483

-357

-299

Net loss

-11,872

-13,788

-11,746

-11,359

-10,078

-8,953

-10,761

-9,163

-8,668

-8,703

-7,486

-6,180

-3,198

-2,809

-2,767

-2,258

-1,684

-1,017

-751

-599

-444

Other comprehensive loss:
Unrealized gain on available-for-sale securities

13

-4

-14

20

3

2

-3

3

48

-49

4

3

-2

1

-8

-

0

-

-

-

-

Comprehensive loss

-11,859

-13,792

-11,760

-11,339

-10,075

-8,951

-10,764

-9,160

-8,620

-8,752

-7,482

-6,177

-3,200

-2,808

-2,775

-2,258

-1,684

-1,017

-751

-599

-444

Net loss per share:
Basic and diluted net loss per share

-0.57

-0.66

-0.57

-0.55

-0.49

-0.51

-0.64

-0.54

-0.51

-0.53

-0.52

-0.43

-0.23

-0.21

-0.21

-0.23

-0.22

-0.13

-0.10

-0.08

-0.06

Weighted average shares used to compute net loss per common share - basic and diluted

20,838

20,799

20,774

20,728

20,679

17,656

16,927

16,881

16,842

16,574

14,381

14,233

13,803

13,315

13,315

9,791

7,565

7,565

7,565

7,565

7,565